VMH must integrate the energy sensing and reproductive functions. Activation of VMH insulin receptor-positive cells by excessive insulin during challenge with a high-fat diet or experimental enhancement of the insulin receptor signaling cascade will signal excess energy availability to the brain. This initiates the process of storing excess energy for the purpose of reproduction, although the lack of a reproductive phenotype in the studies reported here indicates that there are additional circuits controlling that functional link.
Further evidence from other genetic models shows that, in the VMH, multiple redundant signaling pathways could function as energy sensors. Thus, deletion of the insulin receptor in SF-1-expressing cells alone is not sufficient to alter reproductive function; however, deletion of SF-1, which leads to abnormalities in VMH development, does 13 . Although cells expressing the insulin receptor and leptin receptor are located in the dorsomedial part, the pathways responsible for the control link to reproduction are probably situated in the ventrolateral part and could involve estrogen receptor-α 14 . It seems likely that intra-nuclear connections exist that transfer the metabolic sensing message from the medial part to the ventrolateral part, a hypothesis that should be addressed in future studies.
Since its characterization by Cajal, the VMH has been the subject of debate regarding its ratio of CSF insulin to plasma insulin tends to be lower with increasing obesity 11 , and it may be that insulin receptor-expressing cells in the medial VMH monitor insulin and leptin primarily in the CSF through the abovementioned tanycytes, and that this mechanism may be independent of circulating levels in the blood, thereby conserving insulin sensitivity.
The use of modern gene targeting with the Cre-loxP system and SF-1 as a target represents an important strength as well as possibly one of the few weaknesses of these elegant studies: SF-1 is known to be expressed in several peripheral organs, such as the adrenals, pituitary, testis and spleen, and although its presence in the adult brain is believed to be very localized, recent reports have shown that transient expression during development of factors used for gene targeting may lead to 'leakiness' and to potentially misleading results 12 .
Although the exact mechanism of how insulin signaling in VMH regulates second-order neurons, including POMC neurons, needs to be refined, the overall findings of Klöckener et al. 2 provide important advances to our understanding of the functionalities of the VMH. Besides its roles in metabolic regulation, the VMH is also known to be involved in the control of various sexually dimorphic functions such as female mating behavior and gonadotropin secretion. To verify sufficient energy stores for reproduction, the of another subfamily of glutamate receptors, kainate receptors, also rely on association with auxiliary subunits. Using a simple proteomic assay, this group previously identified two proteins, Neto1 and Neto2 (neuropilin tolloid-like 1 and 2), that interact with kainate receptors 3 . Both Neto1 and Neto2 share an identical and unique domain structure representing a new subfamily of transmembrane proteins containing CUB (complement C1r/ C1s, Uegf, Bmp1) and LDLa (low-density lipoprotein receptor class A) domains (Fig. 1a) . Neto1 had been shown to interact with NMDA receptors 4 , but it now seems as though it has more influence on the function of kainate receptors. Straub 
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A study now shows that association of kainate receptors with the auxiliary protein Neto1 confers the slow activation and deactivation kinetics of synaptic responses, as well as the high agonist affinity seen in vivo.
Drug discovery efforts aimed at identifying new and potentially therapeutic compounds rely on detailed knowledge of the composition and structure of the molecules at which new compounds are targeted. Glutamate receptors play a role in many neurological and psychiatric diseases, and thus gaining a better understanding of their basic biology will facilitate drug discovery programs searching for treatments for these diseases. A study in this issue 1 shows that the gating properties of kainatefamily glutamate receptors are altered by association with the auxiliary subunit Neto1.
All voltage-gated ion channels are associated with a wide variety of β-subunits, smaller proteins that alter their salient properties, affecting trafficking, targeting and gating of the channels. Recently, the discovery of a family of transmembrane proteins able to regulate AMPA receptors, called TARPs (transmembrane AMPA receptor regulatory proteins), showed that ligand-gated ion channels also have β-like auxiliary proteins that can markedly change their properties during synaptic transmission. The association of these auxiliary proteins with AMPA receptors was found to be responsible for subtle but critical properties of these receptors in neurons that heterologous expression systems do not reproduce 2 . In a study in this issue 1 , Straub et al. demonstrate that the characteristic slow kinetics and high agonist affinity n e w s a n d v i e w s function of kainate receptors, through the actions of Neto proteins on two aspects critical for receptor signaling: membrane location and channel gating.
What does association of Neto1 with kai nate receptors represent from a functional point of view? Straub et al. 1 stimulated mossy fibers while recording from CA3 pyramidal cells in slices from wild-type and Neto1 knockout mice. The charge transfer was reduced 3-4 fold in knockout mice at several stimulation frequencies. Given the small amplitude of kainate receptor synaptic responses and the lack of adequate pharmacological tools, the role of these receptors in synaptic transmission and plasticity is not entirely understood. However, it has been proposed that the unusually long EPSCs generated by kainate receptors determine some integrative features of excitatory transmission-in particular, coupling of excitatory postsynaptic potentials (EPSPs) to spikes 8 . Indeed, synaptically activated kainate receptors have indicate that this happens without any decline in surface expression of kainate receptors or redistribution to extrasynaptic sites. Therefore, Straub et al. conclude that changes in gating properties-namely, the speeding of desensitization and deactivation kinetics-of kainate receptors in the absence of Neto1 completely accounts for the reduction of the synaptic current in Neto1 knockout mice.
Complementary results from another new study, however, indicate that this may not be the case for other kainate receptor subtypes. Copits et al. 7 found that Neto2 but not Neto1 promotes surface localization and delivery to synapses of GluK1-containing kainate receptors in cultured hippocampal neurons. In agreement with the data from Straub et al., this enhanced density of membrane receptors in the presence of Neto2 does not fully account for the observed increase in kainatemediated response. Therefore, these new data confirm and extend the idea that Neto proteins constitute key determinants of the the rapid deactivation of kainate currents is decelerated. This suggests an increase in affinity of the receptor for its agonist when the receptors are in the presence of Neto1. The rate of desensitization is also slowed, whereas recovery from the desensitized state happens more quickly, such that some steady current remains during long agonist application. Consistent with its action on gating properties, Neto1 was shown biochemically to increase the affinity for agonist.
Recombinant kainate and AMPA receptors have similar activation-inactivation kinetics, and both show similar affinity for glutamate 5 . Therefore, if both receptor subtypes localize at the synapse, one would expect similar kinetics for the kainate-and AMPA receptor-mediated synaptic responses. However, it was found in pyramidal neurons of the CA3 region of the hippocampus and subsequently in other hippocampal neurons that kainate receptor excitatory postsynaptic currents (EPSCs) are characteristically slower and smaller, something that was unanticipated from properties observed in recombinant receptors 6 . The lack of effect of altering glutamate uptake on the response kinetics of kainate receptors ruled out the possibility that they might be located perisynaptically and therefore activated by glutamate spillover 6 . The reason for this discrepancy in kinetics between recombinant receptors and those in intact neurons has therefore not been convincingly explained until now.
Neto1 and Neto2 present a complementary expression profile in the mouse brain. While Neto2 is abundantly expressed in cerebellar granule cells and cortical neurons, Neto1 is mostly expressed in the hippocampus, particularly where high affinity kainate receptors are known to be enriched, in the CA3 stratum lucidum (Fig. 1b,c) . To investigate whether the expression of Neto1 could be the reason for the high-affinity binding by kainate receptors in the hippocampus, Straub et al. used a mouse deficient for Neto1.
Kainate binding affinity is reduced in the CA3 stratum lucidum of the Neto1 knockout, indicating that Neto1 confers high-affinity binding on hippocampal kainate receptors. Electrophysiological recordings of kai nate EPSCs evoked by mossy fiber activation in hippocampal slices from these knockout mice revealed that the typical slow responses are instead as fast as those mediated by AMPA receptors in the absence of Neto1 (Fig. 1d,e) . Curiously enough, their amplitude is also reduced, and the response to bath-applied kainate in CA3 neurons is nearly three times smaller in Neto1 knockout hippocampi. However, careful biochemical experiments n e w s a n d v i e w s with a potential for treating many neurological disorders depend to a large extent on the availability of proper targets and assays. The CA3 region of the hippocampus is highly epileptogenic, and kainate receptors seem to be in part responsible for this property 14 . Given the functional impact that the interaction of Neto1 with kainate receptors has in CA3, these data unveil a new target for therapeutic intervention. If a drug disrupting Neto1-kainate receptor interaction could be found or designed, it could reduce hippocampal excitability, likely depressing the threshold for seizure development, because some types of synaptic transmission would be selectively impaired in the absence of this interaction. Therefore, an exact knowledge of native receptor architecture is fundamental for developing new drugs and for the accuracy of these assays. The many brain diseases in which glutamate receptors are involved, for which adequate treatments are as yet unavailable, indicate that research into the most basic biology of these receptors may have substantial consequences for improving human health.
